ArticleLaryngoscope investigative otolaryngology2026
Demographic and Comorbidity Associations With Disease Severity and Bony Dehiscence in AFRS.
Article in Laryngoscope investigative otolaryngology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The purpose of this study is to explore and describe possible demographic factors and comorbidities as they relate to disease severity of allergic fungal rhinosinusitis (AFRS) on initial presentation. Methods: A retrospective review was conducted on 153 patients with AFRS seen at a tertiary care center. Demographics, comorbidities, SNOT-22 scores, Lund-Kennedy endoscopy scores, and Lund-Mackay CT scores, and presence of bony dehiscence at various skull base and orbital sites were recorded. Patients who had previous sinus surgery were excluded. Statistical analyses included t-tests and ANOVA. Results: Within our cohort ( Conclusion: In our patient cohort with AFRS, African-American race and age were significantly associated with worse presentation of disease based on both subjective (SNOT-22 scores) and objective (Lund-Mackay scores) data. When looking specifically at patients with evidence of bony erosion on presentation, we also found asthma to be associated with more severe disease. These findings suggest that comorbid asthma may be a useful marker for identifying patients at greater risk of greater disease severity at initial presentation. Level of Evidence: IV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.